Cargando…

Epitranscriptomic Reader HNRNPA2B1 Confers Endocrine Resistance to Breast Cancer Cells

Despite new combination therapies improving survival of breast cancer patients with estrogen receptor α (ER+) tumors, the molecular mechanisms for endocrine-resistant metastatic disease remain unresolved. HNRNPA2B1 (Heterogeneous Nuclear Ribonucleoprotein A2/B1), an RNA binding protein that function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klinge, Carolyn M, Petri, Belinda J, Piell, Kellianne M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Steroid Hormones and Receptors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090017/ http://dx.doi.org/10.1210/jendso/bvab048.1643

Ejemplares similares

OR09-06 HNRNPA2B1 Mediates Endocrine-Sensitivity and Alters PSAT1 in Breast Cancer Cells
por: Klinge, Carolyn M, et al.
Publicado: (2020)

SUN-009 N(6)-Methyladenosine Reader HNRNPA2B1 Regulates Tamoxifen-Sensitivity in Breast Cancer Cells
por: Klinge, Carolyn, et al.
Publicado: (2019)

OR07-2 Endocrine Response And Resistance Is Driven By Novel Transcriptional Co-Regulator Activity In Invasive Lobular Carcinoma Of The Breast
por: Costello, James, et al.
Publicado: (2022)

Association of Maternal-Neonatal Steroids With Early Pregnancy Endocrine Disrupting Chemicals and Pregnancy Outcomes
por: Banker, Margaret, et al.
Publicado: (2021)

Improving the Diagnosis, Treatment, and Prevention of Endocrine Diseases Through Accurate and Reliable Laboratory Measurements With CDC Clinical Standardization Programs
por: Sugahara, Otoe, et al.
Publicado: (2021)

SAT-733 Improving the Diagnosis, Treatment, and Prevention of Endocrine Diseases Through Accurate and Reliable Laboratory Measurements with CDC’s Clinical Standardization Programs
por: Sugahara, Otoe, et al.
Publicado: (2020)

SUN-006 Lasofoxifene Achieves Potent Anti-Tumor Activity in Hormone-Resistant Breast Tumors by Maintaining High Affinity Binding for Y537S ERα
por: Fanning, Sean, et al.
Publicado: (2019)

Androgen Receptor Highjacks ErbB-2 Nuclear Function to Induce Triple Negative Breast Cancer Growth
por: Deamicis, Agustina Roldán, et al.
Publicado: (2021)

SUN-LB135 Estrogen Receptor Beta Inhibits NFkB Signaling to Inhibit Triple Negative Breast Cancer
por: Aspros, Kirsten, et al.
Publicado: (2020)

Disruption of Adipose Tissue Metabolism by Glucocorticoids Is Attenuated With LXRβ Antagonism
por: Li, Jia Xu, et al.
Publicado: (2021)

Quantifying the Protein Levels of All Nuclear Hormone Receptors by Mass Spectrometry
por: Saikali, Michael Fadi, et al.
Publicado: (2021)

The Transcriptional Function of GRHL2 in Hormone-Dependent Breast Cancers
por: Reese, Rebecca, et al.
Publicado: (2021)

Studying the Genomic Role of Cathepsin-D in ER(+) Breast Cancer
por: Dianati, Elham, et al.
Publicado: (2021)

OR26-5 Functional Analysis of Estrogen-Regulated Enhancer RNAs in Breast Cancer Cells
por: Hou, Tim, et al.
Publicado: (2019)

Differential Genomic Interactions Drive Progesterone Receptor Isoform Specific Functions in Breast Cancer
por: Doan, Tram B, et al.
Publicado: (2021)

SUN-748 Functional Characterization of Estrogen-Regulated LncRNA16 in ER+ Breast Cancer
por: Yang, Barbara, et al.
Publicado: (2020)

SAT-008 Overcoming BCL-2 Resistance in Glucocorticoid-Treated Tumor Lymphoid Cells
por: Bortner, Carl, et al.
Publicado: (2019)

SUN-012 Investigating the Effect of GRHL2 on pS118-ER Transcriptional Activity in Breast Cancer
por: Reese, Rebecca, et al.
Publicado: (2019)

RF03 | PMON289 KLF4 drives estrogen driven tumor heterogeneity in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2022)

SUN-028 Role of Estrogen Receptor Alpha (ERa) Acetylation in Estrogen-Dependent Gene Regulation in Breast Cancers
por: Vasquez, Yasmin, et al.
Publicado: (2019)

OR12-05 MDC1 Is a Novel Estrogen Receptor Co-Regulator in Invasive Lobular Carcinoma of the Breast
por: Bordeaux, Evelyn K, et al.
Publicado: (2020)

ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022)

OR26-1 Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem-Like and Proliferative Breast Cancer Cell Fates
por: Truong, Thu, et al.
Publicado: (2019)

SUN-743 Understanding the Role of Pancreas and Testis Specific lncRNA86 in Estrogen-Dependent Signaling in Breast Cancer
por: Ramos, Enrique Ivan, et al.
Publicado: (2020)

SAT-737 Low-Dose Testosterone Augmentation for Treatment-Resistant Depression in Women: An 8-Week, Two-Site, Randomized, Placebo-Controlled Study
por: Dichtel, Laura E, et al.
Publicado: (2020)

Persistent COUP-TFII Expression Underlies the Myopathy and Impaired Muscle Regeneration Observed in Resistance to Thyroid Hormone-Alpha
por: Aguiari, Paola, et al.
Publicado: (2021)

SUN-011 Identification Of Regulators Of Estrogenic Signalling In ER-positive Breast Cancer Cells By Whole Genome shRNA Screening
por: Kulpa, Justyna, et al.
Publicado: (2019)

SUN-005 DAX-1 Inhibition of Estrogen Receptor and Metastasis Target Genes in Estrogen Receptor Positive Breast Cancer Cells
por: Tzagarakis-Foster, Christina, et al.
Publicado: (2019)

RF03 | PMON297 Connecting Fluctuations in Estrogen Production, Release, and Action with Hormone-Dependent Gene Expression in Breast Cancers
por: Kim, Hyung Bum, et al.
Publicado: (2022)

OR26-2 Phosphorylation of Estrogen Receptor Alpha is Required for Mammary Gland Development and MCF-7 Breast Tumor Response to Estradiol and Tamoxifen
por: Emneser, Waleed, et al.
Publicado: (2019)

SUN-008 The Glucocorticoid Receptor Is Essential For TGFβ and p38 MAPK Mediated Cancer Phenotypes in Triple Negative Breast Cancer
por: Perez Kerkvliet, Carlos, et al.
Publicado: (2019)

OR07-1 Estrogen-regulated Enhancer RNAs Contain a Functional Motif that Controls Enhancer Assembly and Function in Breast Cancer Cells
por: Hou, Tim, et al.
Publicado: (2022)

SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer
por: Oksala, Riikka, et al.
Publicado: (2019)

SAT-734 HSD3B1 Expression in the Human Immune System
por: McManus, Jeffrey M, et al.
Publicado: (2020)

OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020)

SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies
por: Snaterse, Gido, et al.
Publicado: (2019)

HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
por: Klinge, Carolyn M., et al.
Publicado: (2019)

SUN-742 Roles of Progesterone Receptor Isoform B in Non-Small Cell Lung Cancer Tumor Progression
por: Asavasupreechar, Teeranut, et al.
Publicado: (2020)

ODP441 NErbB-2 and Androgen Receptor Regulate a Gene Signature Involved in Immune Response and Favorable Outcome in TNBC
por: Elizalde, Patricia, et al.
Publicado: (2022)

ODP440 Characterization of the Major Single Nucleotide Polymorphic Variants of Aldo-Keto Reductase 1c3 (Type 5 17β-Hydroxysteroid Dehydrogenase)
por: Detlefsen, Andrea J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2t43ssrhs074n61riqql7icmbk